The peptic ulcer and gastro-oesophageal reflux diseases medicine sales in Italy are projected to decrease from 673.3 million Euros in 2024 to 581.4 million Euros in 2028. This forecast indicates a steady decline over the five-year period. Compared to 2023, where actual data stood at similar levels, year-on-year variation shows a consistent reduction in sales, with an average decrease per year, resulting in a negative compound annual growth rate (CAGR).
Future trends to watch for include:
- Changes in lifestyle and dietary habits which could reduce the incidence of these conditions
- Potential advancements in medical treatments or alternative therapies impacting traditional medicine sales
- Regulatory changes affecting drug pricing or availability
